Lympro Marketing example for the Alzheimer's RUO m
Post# of 30028
Posted On: 11/16/2014 9:34:23 AM
Lympro Marketing example for the Alzheimer's RUO market:
'Improve Clinical Trial Success with Lympro':
Almost all Alzheimer's clinical trials fail due to incorrect diagnosis and carry significant cost. Lympro is a simple blood test that can identify even early stage Alzheimer's at 30% less cost - priceless for Pharma companies development programs and for families waiting for a treatment.
Lympro is Effective:
'Improves clinical trial success' with at least 90% accuracy.
Lympro is Stage Independent:
'Enhances patient targeting in clinical trials' with equal efficacy proven in early, mid, and late stage Alzheimer's.
Lympro is Convenient:
'Improved speed of clinical trials' using a simple blood test with 1 biomarker.
Lympro is Cost Effective:
'Reduces clinical trial cost' by at least 30% compared to currently available diagnostics.
Very compelling story about to be in the market...
'Improve Clinical Trial Success with Lympro':
Almost all Alzheimer's clinical trials fail due to incorrect diagnosis and carry significant cost. Lympro is a simple blood test that can identify even early stage Alzheimer's at 30% less cost - priceless for Pharma companies development programs and for families waiting for a treatment.
Lympro is Effective:
'Improves clinical trial success' with at least 90% accuracy.
Lympro is Stage Independent:
'Enhances patient targeting in clinical trials' with equal efficacy proven in early, mid, and late stage Alzheimer's.
Lympro is Convenient:
'Improved speed of clinical trials' using a simple blood test with 1 biomarker.
Lympro is Cost Effective:
'Reduces clinical trial cost' by at least 30% compared to currently available diagnostics.
Very compelling story about to be in the market...
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼